Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Change in Acquisitions & Divestments (2022 - 2026)

Immuneering's Change in Acquisitions & Divestments history spans 4 years, with the latest figure at $9.0 million for Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A to $9.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $9.0 million, a 14.29% decrease, with the full-year FY2024 number at $31.9 million, down 38.95% from a year prior.
  • Change in Acquisitions & Divestments came in at $9.0 million for Q1 2026, up from $5.5 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $32.3 million in Q2 2022, with the low at $5.0 million in Q3 2023.
  • Historically, Change in Acquisitions & Divestments has averaged $15.5 million across 4 years, with a median of $19.0 million in 2023.
  • Biggest five-year swings in Change in Acquisitions & Divestments: tumbled 74.03% in 2023 and later grew 12.79% in 2024.
  • Year by year, Change in Acquisitions & Divestments stood at $20.6 million in 2022, then decreased by 7.52% to $19.0 million in 2023, then crashed by 71.13% to $5.5 million in 2024, then surged by 63.64% to $9.0 million in 2026.
  • Business Quant data shows Change in Acquisitions & Divestments for IMRX at $9.0 million in Q1 2026, $5.5 million in Q4 2024, and $5.0 million in Q2 2024.